Cargando…
CXCR4 Antagonists as Stem Cell Mobilizers and Therapy Sensitizers for Acute Myeloid Leukemia and Glioblastoma?
Glioblastoma is the most aggressive and malignant primary brain tumor in adults and has a poor patient survival of only 20 months after diagnosis. This poor patient survival is at least partly caused by glioblastoma stem cells (GSCs), which are slowly-dividing and therefore therapy-resistant. GSCs a...
Autores principales: | Hira, Vashendriya V.V., Van Noorden, Cornelis J.F., Molenaar, Remco J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168055/ https://www.ncbi.nlm.nih.gov/pubmed/32079173 http://dx.doi.org/10.3390/biology9020031 |
Ejemplares similares
-
Energy Metabolism in IDH1 Wild-Type and IDH1-Mutated Glioblastoma Stem Cells: A Novel Target for Therapy?
por: van Noorden, Cornelis J.F., et al.
Publicado: (2021) -
Metabolic Mapping: Quantitative Enzyme Cytochemistry and Histochemistry to Determine the Activity of Dehydrogenases in Cells and Tissues
por: Molenaar, Remco J., et al.
Publicado: (2018) -
IDH1-mutant cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity
por: Khurshed, Mohammed, et al.
Publicado: (2018) -
Cysteine cathepsins B, X and K expression in peri-arteriolar glioblastoma stem cell niches
por: Breznik, Barbara, et al.
Publicado: (2018) -
Mutational profiling of kinases in glioblastoma
por: Bleeker, Fonnet E, et al.
Publicado: (2014)